UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Molecular Mechanisms of the Efficacy of Cold Atmospheric Pressure Plasma (CAP) in Cancer Treatment

Cancers, 2020-01, Vol.12 (2), p.269

2020

Volltextzugriff (PDF)

Biological Risk Assessment of Three Dental Composite Materials following Gas Plasma Exposure

Molecules (Basel, Switzerland), 2022-07, Vol.27 (14), p.4519

2022

Volltextzugriff (PDF)

Mechanical and Plasma Electrolytic Polishing of Dental Alloys

Materials, 2023-09, Vol.16 (18), p.6222

2023

Volltextzugriff (PDF)

Comparative Sample Preparation Using Focused Ion Beam and Ultramicrotomy of Human Dental Enamel and Dentine for Multimicroscopic Imaging at Micro- and Nanoscale

Materials, 2022-04, Vol.15 (9), p.3084

2022

Volltextzugriff (PDF)

Plasma medical oncology: Immunological interpretation of head and neck squamous cell carcinoma

Plasma processes and polymers, 2020-10, Vol.17 (10), p.n/a

2020

Volltextzugriff (PDF)

Plasma Medical Oncology: Long-Term Results With Focus On Immunity Research

Clinical plasma medicine, 2018-02, Vol.9, p.48-48

2018

Volltextzugriff (PDF)

Kinder- und Jugendhilfe - Eine Chance fuer "Schreibabys"?

Forum Erziehungshilfen, 2003, Vol.9 (5), p.301-309

Witzke, Katharina

2003

Volltextzugriff (PDF)

Five‐Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study

American journal of transplantation, 2015-01, Vol.15 (1), p.119-128

2015

Volltextzugriff (PDF)

Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Ledipasvir in Renal Transplant Recipients

Transplantation, 2017-05, Vol.101 (5), p.980

2017

Volltextzugriff (PDF)

IL-21 dependent Granzyme B production of B-cells is decreased in patients with lupus nephritis

Clinical immunology (Orlando, Fla.), 2018-03, Vol.188, p.45-51

2018

Volltextzugriff (PDF)

Neurobehavioral consequences of small molecule-drug immunosuppression

Neuropharmacology, 2015-09, Vol.96 (Pt A), p.83-93

2015

Volltextzugriff (PDF)

Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3‐Year Results From the Randomized ZEUS Study

American journal of transplantation, 2012-06, Vol.12 (6), p.1528-1540

2012

Volltextzugriff (PDF)

Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection

Therapeutic advances in neurological disorders, 2021, Vol.14, p.1756286421993701-1756286421993701

2021

Volltextzugriff (PDF)

SP754TREATMENT WITH GRAZOPREVIR/ELBASVIR FOR RENAL TRANSPLANT RECIPIENTS WITH CHRONIC HEPATITIS C VIRUS INFEKTION AND IMPAIRED ALLOGRAFT FUNCTION

Nephrology, dialysis, transplantation, 2018-05, Vol.33 (suppl_1), p.i602-i603

2018

Volltextzugriff (PDF)

Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study

BMC nephrology, 2018-06, Vol.19 (1), p.154-154, Article 154

2018

Volltextzugriff (PDF)

Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study

Clinical nephrology, 2015-01, Vol.83 (1), p.11

2015

Volltextzugriff (PDF)

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials

BMC nephrology, 2018-09, Vol.19 (1), p.237-237, Article 237

2018

Volltextzugriff (PDF)

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

Nature cancer, 2023-01, Vol.4 (1), p.96

2023

Volltextzugriff (PDF)

Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trial

Clinical nephrology, 2016-04, Vol.85 (4), p.215

2016

Volltextzugriff (PDF)

Five‐year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low‐exposure cyclosporine versus standard therapy

American journal of transplantation, 2018-12, Vol.18 (12), p.2965-2976

2018

Volltextzugriff (PDF)

Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function

Transplantation direct, 2019-01, Vol.5 (1), p.e419-e419

2019

Volltextzugriff (PDF)

Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)

Infection, 2024-04

2024

Volltextzugriff (PDF)

High Frequencies of Anti-Host Reactive CD8+ T Cells Ignore Non-Hematopoietic Antigen after Bone Marrow Transplantation in a Murine Model

Cellular physiology and biochemistry, 2016-04, Vol.38 (4), p.1343-1353

2016

Volltextzugriff (PDF)

1886. External Validation of the 4C Mortality Score and the qSOFA for Different Variants of Concerns of SARS-CoV-2 Using Data of the NAPKON Cross-Sectoral Cohort Platform (SUEP)

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(17)
Humans
(12)
Adult
(8)
Female
(8)
Kidney Transplantation
(8)
Male
(8)
Middle Aged
(8)
Transplantation
(8)
Everolimus
(7)
Aged
(6)
Cyclosporine
(5)
Nephrology
(5)
Surgery
(5)
Transplants & Implants
(5)
Adolescent
(4)
Calcineurin Inhibitors
(4)
Cyclosporine - Administration & Dosage
(4)
Follow-Up Studies
(4)
Immunosuppressive Agents - Administration & Dosage
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular Mechanisms of the Efficacy of Cold Atmospheric Pressure Plasma (CAP) in Cancer Treatment

Biological Risk Assessment of Three Dental Composite Materials following Gas Plasma Exposure

Mechanical and Plasma Electrolytic Polishing of Dental Alloys

Comparative Sample Preparation Using Focused Ion Beam and Ultramicrotomy of Human Dental Enamel and Dentine for Multimicroscopic Imaging at Micro- and Nanoscale

Plasma medical oncology: Immunological interpretation of head and neck squamous cell carcinoma

Plasma Medical Oncology: Long-Term Results With Focus On Immunity Research

Kinder- und Jugendhilfe - Eine Chance fuer "Schreibabys"?

Five‐Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study

Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Ledipasvir in Renal Transplant Recipients

IL-21 dependent Granzyme B production of B-cells is decreased in patients with lupus nephritis

Neurobehavioral consequences of small molecule-drug immunosuppression

Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3‐Year Results From the Randomized ZEUS Study

Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection

SP754TREATMENT WITH GRAZOPREVIR/ELBASVIR FOR RENAL TRANSPLANT RECIPIENTS WITH CHRONIC HEPATITIS C VIRUS INFEKTION AND IMPAIRED ALLOGRAFT FUNCTION

Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study

Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trial

Five‐year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low‐exposure cyclosporine versus standard therapy

Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function

Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)

High Frequencies of Anti-Host Reactive CD8+ T Cells Ignore Non-Hematopoietic Antigen after Bone Marrow Transplantation in a Murine Model

1886. External Validation of the 4C Mortality Score and the qSOFA for Different Variants of Concerns of SARS-CoV-2 Using Data of the NAPKON Cross-Sectoral Cohort Platform (SUEP)

1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial

Suchergebnisse filtern